Press Releases
2024 L&H assumption review completed, Group solvency ratio of 203%
4357
-
-
Expert viewsNovember 12, 2024
How consumer groups, patient representatives, and the insurance industry are working in partnership to help protect cancer survivors
-
-
-
-
-
Expert viewsOctober 30, 2024
Using Pandemic Mortality Experience for Pricing Longevity
-
NewsOctober 25, 2024
Winner of the 2024 Most Innovative Product/Service Award - General Insurance
-
-
Our expertsRoshan is a longevity specialist with more than 10 years of experience in the field.
-
- Review of neurological, developmental, and mental health conditions
-
Drugs developed for the treatment of diabetes such as semaglutide (marketed as Ozempic or Wegovy), liraglutide (Saxenda), and tirzepatide (Mounjaro or Zepbound) are being used to decrease the weight of obesity risks: